Literature DB >> 19208511

Efficacy and safety of moderately steatotic donor liver in transplantation.

Feng Gao1, Xiao Xu, Qi Ling, Jian Wu, Lin Zhou, Hai-Yang Xie, Hui-Ping Wang, Shu-Sen Zheng.   

Abstract

BACKGROUND: The discrepancy between available livers and requests for transplantation has forced many centers to use marginal donors in order to expand the donor pool. Many previous studies have demonstrated controversial results of the application of steatotic liver grafts. The aim of the present study was to summarize our experience and evaluate the value of steatotic liver grafts.
METHODS: The clinical and follow-up data of 24 adult patients receiving moderately steatotic liver grafts (30%-60%) from May 2003 to June 2005 (group 1) were analyzed. After matching for age, gender, model for end-stage liver diseases score and cold ischemia time, another 24 patients receiving liver grafts with steatosis less than 30% were chosen as the control group (group 2). The patient and graft outcomes were compared between the two groups.
RESULTS: No difference of liver and kidney functions in the first post-transplant week was found between the two groups (P>0.05). Neither the incidence of early allograft dysfunction and acute kidney injury nor the patient survival rates (3 months, 6 months and 1 year) showed differences between groups 1 and 2 (P>0.05).
CONCLUSION: Moderately steatotic liver grafts provide adequate function in the first phase after transplantation and can be used for transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19208511

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  8 in total

1.  Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy.

Authors:  Amit K Mathur; Amir A Ghaferi; Kristen Sell; Christopher J Sonnenday; Michael J Englesbe; Theodore H Welling
Journal:  J Gastrointest Surg       Date:  2010-02-06       Impact factor: 3.452

Review 2.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

3.  Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure.

Authors:  Qi Ling; Xiao Xu; Qiang Wei; Xiaoli Liu; Haijun Guo; Li Zhuang; Jiajia Chen; Qi Xia; Haiyang Xie; Jian Wu; Shusen Zheng; Lanjuan Li
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

Review 4.  Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Authors:  Chenjiao Wu; Chao Lu; Chengfu Xu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis.

Authors:  Qiong-Yue Zhang; Qiong-Fang Zhang; Da-Zhi Zhang
Journal:  Biomed Res Int       Date:  2019-05-14       Impact factor: 3.411

Review 6.  Feasibility of using marginal liver grafts in living donor liver transplantation.

Authors:  Xiang Lan; Hua Zhang; Hong-Yu Li; Ke-Fei Chen; Fei Liu; Yong-Gang Wei; Bo Li
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

Review 7.  Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.

Authors:  Kelley Núñez; Paul Thevenot; Abeer Alfadhli; Ari Cohen
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

8.  A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation.

Authors:  Justin A Steggerda; Daniel Borja-Cacho; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Matthew B Bloom; Andrew S Klein; Irene K Kim
Journal:  Transplant Direct       Date:  2022-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.